A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
SEED Therapeutics, Inc.
SEED Therapeutics, Inc.
St. Jude Children's Research Hospital
Seattle Children's Hospital
Seattle Children's Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Valent Technologies, LLC
3B Pharmaceuticals GmbH
Children's National Research Institute
Emory University
Bayer
New York Medical College
Children's National Research Institute
Case Comprehensive Cancer Center
Gradalis, Inc.
Emory University
Emory University
Pfizer
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)